NCT03140514View on ClinicalTrials.gov

Urine CXCL10 Chemokine Monitoring Post-renal Transplant

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

July 15, 2022

Study Completion Date

July 15, 2022

Conditions
Renal Transplant Rejection
Interventions
DRUG

Rejection treatment according to clinical standard-of-care

Standard-of-care treatment is based on the severity and phenotype of biopsy-proven rejection

Trial Locations (1)

4031

University Hospital Basel, Transplantation Immunology & Nephrology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03140514 - Urine CXCL10 Chemokine Monitoring Post-renal Transplant | Biotech Hunter | Biotech Hunter